This site uses analytics cookies
We use Countly to measure audience and improve your experience. This data remains anonymous and is not shared with third parties.
March 9, 2023
Ad Scientiam was selected by a jury of French and German experts composed of specialists in the German medtech market, pharmaceutical industry, digital specialists, and Bpifrance.
This program will support Ad Scientiam in developing its activities in Germany.
Ad Scientiam was selected by the Ile-de-France Regional Council under the PM'up program, as part of the #Leader strategy for innovation.
April 1, 2021
MSCopilot® development was selected for innovation support under the Innov'up Leader PIA program, funded by the State and Île-de-France Region.
August 13, 2020
At the 12th Congress of the European Academy of Neurology in Geneva, we present the first encouraging 1-year results from our MS-DETECT and MS-FLOWER studies, confirming the reliability of MSCopilot® for long-term monitoring of multiple sclerosis.
June 29, 2026
Talk to our experts and discover how our solutions integrate into your practice or studies.